FeesSafety
Pluang+

Daré Bioscience CEO to present women's health innovations at Stifel 2026 Healthcare Conference

Market News
04 Nov 2026, 16:05 WIB
GlobeNewsWire
View Source
Neutral
Daré Bioscience CEO to present women's health innovations at Stifel 2026 Healthcare Conference

Daré Bioscience announced that CEO Sabrina Martucci Johnson will present the company's women's health portfolio, commercial strategy, and clinical pipeline at Stifel’s 2026 Healthcare Conference in New York on November 11. The presentation will highlight Daré's progress in developing innovative solutions addressing unmet needs in women's health. The event will be webcast live and available for replay for 90 days, providing investors and the public insight into the company's advancements in areas such as contraception, menopause, and sexual health.

Daré Bioscience's upcoming presentation at Stifel’s 2026 Healthcare Conference is noted here with Pluang's Health-sector market data as context. For readers following this sector, as of Nov 04, 2026 20:41 WIB, 127 of 150 priced US Health stocks rose while 19 fell. Among notable movers, HCA Health Inc reached USD 496.00 with a 7.16% increase and a typical hold time of 77 days, contrasting with Medline Inc. at USD 36.51 gaining 7.10% and a much shorter hold time of 9 days, while Tenet Healthcare Corporation traded at USD 282.52 but experienced a 5.94% rise despite 100% sell order activity and a 17-day hold time.

More News

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment named Leader by Everest Group for US IT staffing and consulting excellence

Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...

Market News
Bullish
25 minutes ago
Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma to present at multiple investor conferences in November and December 2026

Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...

Market News
Neutral
1 hour ago
etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro acquires Argentine fintech LB Finanzas to expand in Latin America

etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...

Company Fundamentals
Bullish
1 hour ago
JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...

Company Fundamentals
Neutral
4 hours ago
KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App